NewGenIvf Group (NIVF) Projected to Release Quarterly Earnings on Wednesday

NewGenIvf Group (NASDAQ:NIVF) is anticipated to post its resultson Wednesday, September 2nd. Analysts expect NewGenIvf Group to post earnings of $6.06 per share and revenue of $20.10 million for the quarter.

NewGenIvf Group Trading Up 6.6%

NASDAQ:NIVF opened at $0.45 on Tuesday. The stock’s 50 day moving average price is $1.02 and its 200 day moving average price is $3.85. The company has a debt-to-equity ratio of 0.16, a quick ratio of 2.98 and a current ratio of 3.12. NewGenIvf Group has a 52 week low of $0.38 and a 52 week high of $513.00.

Wall Street Analysts Forecast Growth

NIVF has been the topic of several analyst reports. Wall Street Zen upgraded shares of NewGenIvf Group to a “hold” rating in a research note on Saturday, July 4th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Sell”.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.